Colleen Moretti

Watch Dr. Neha S. Korde, an assistant professor in multiple myeloma service in the Division of Hematology at Memorial Sloan Kettering Cancer Center, present on MGUS/smoldering myeloma.

Keytruda was well tolerated and demonstrated practice-changing responses with potential for a curative approach in a group of patients with advanced endometrial cancer, according to an expert.

To address symptoms from myeloma that is resistant to treatment, education and communication with care teams are key.

Patients with stage 3 melanoma, a type of skin cancer, that has metastasized to the lymph nodes may benefit from skipping lymph node removal surgery and receiving treatment with adjuvant therapy, although more research is needed in this area.

One of the hurdles, according to the study’s lead author, is that many patients with cancer are worried about receiving a placebo in a clinical trial.

In honor of CURE®’s 20th anniversary, we spoke with experts on how the past 20 years have revolutionized multiple myeloma treatment.

Donna McNutt uses her love of fashion to find confidence and motivation — and shares it with others — after a myeloma diagnosis.

Durable and deep responses occurred in patients with multiple myeloma after use of a particular CAR-T cell therapy

Recently approved, by the Food and Drug Administration, Besremi has demonstrated to be effective and safe for patients with polycythemia vera — adding hope to their treatment regimen.

Sara Montiel shares her experience and how time helped her find the confidence she needed for herself and her young daughter

Increased resources and technological advances have allowed cancer survivors experiencing psychological side effects to seek help that might not have been available to them 20 years ago.

During his college years, Matt Froestad received the diagnosis not once but twice following self-exams.

Prehab and rehab may help patients with cancer who are receiving CAR-T cell therapy return to health or even better, but there are still challenges.

The MEK inhibitor trametinib should be considered a new standard of care for patients with a rare subtype of ovarian cancer, explains an expert from The University of Texas MD Anderson Cancer Center.

Patients with cancer, their friends and families can enjoy these guilt-free recipes when sitting down to watch the Los Angeles Rams and Cincinnati Bengals go toe-to-toe during Super Bowl 56 on Sunday.

After four years of additional follow-up, survival continued to improve and side effects remained tolerable in patients with anaplastic thyroid cancer receiving Tafinlar plus Mekinist.

Patients with lung cancer whose symptoms were managed by automated alerts to their care team through an electronic system after surgery had fewer post-surgical complications than patients who received standard care.

Patients with stage 3 colon cancer should feel empowered to start a healthy lifestyle and diet, says a researcher, after recent study results demonstrated positive survival and recurrence outcomes.

For patients with myelofibrosis, previously treated with Jakafi, momelotinib could be a major drug approval coming up, according to an expert.

Kymriah may represent a more effective option than currently available treatments for patients with heavily pretreated follicular lymphoma, according to an expert from The University of Texas MD Anderson Cancer Center.

The use of a non-invasive procedure combined with Lenvima plus Tyvyt demonstrated safe and effective results in patients with liver cancer not eligible for surgical resection.

The survey results also showed that those who have received a cancer diagnosis have faced more setbacks when it comes to working during the pandemic.

Cancer survivors may experience psychological side effects of cancer and can benefit from stress management interventions, although these in-person services are often limited.

As cancer incidence increases in young adults, understanding the genomic profiles of tumors in young adults may guide treatment options such as immunotherapy.

Additional advancements in how radical prostatectomy is performed are needed to improve other urinary outcomes such as good urinary function and social incontinence.

An end-of-life conversation may increase hope in patients with cancer, however many patients may be getting it from oncologists when it’s a “too little too late,” an expert said.

The drug Venclexta may address an unmet need for patients with Waldenström macroglobulinemia via a non-chemotherapeutic, safe and effective treatment option.

The data demonstrated that the combination of Imbruvica and Rituxan conferred superior progression-free survival results in patients with previously untreated chronic lymphocytic leukemia, compared with the chemotherapies fludarabine and cyclophosphamide plus Rituxan.

Recent results demonstrated durable responses and no new side effects for Venclexta plus Imbruvica in pretreated chronic lymphocytic leukemia.

On this episode of the “Cancer Horizons” podcast, a woman with multiple myeloma shares how she made the best of her cancer treatment process by channeling her emotions through fashion expression.